Anew MedicalGRMLWPreferred / convertible

13F holders, Q4 2025 (December 31)
7holders +1
1new positions
0sold out
1famous investor
$0.10avg. 13F price*

At the end of Q4 2025, 7 institutions reported holding Anew Medical Inc. (GRMLW) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Aristeia Capital, L.L.C. ($114K), D. E. Shaw & Co. ($29K) and Susquehanna International Group, LLP ($21K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Anew Medical Inc.
Filed as
KLOTHO NEUROSCIENCES INC (Q4 2025)
CUSIP
49876K111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q3 2024: 22Q3 2024Q4 2024: 22Q4 2024Q1 2025: 19Q1 2025Q2 2025: 7Q2 2025Q3 2025: 6Q3 2025Q4 2025: 7Q4 2025Q1 2026: 5Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions1$103
Exits0$0

All 13F filers, Q3 2025 → Q4 2025: 1,077 shares bought and 40,075 shares sold, net −38,998 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 7 holders

Aristeia Capital, L.L.C. — No change 1,106,754 $114K
D. E. Shaw & Co. — No change 300,000 $29K
Susquehanna International Group, LLP — Reduce -15.5% 217,879 $21K
Clear Street Group Inc. — Reduce -0.2% 54,102 $5K
OneDigital Investment Advisors LLC — No change 10,000 $959
UBS Group AG — New 1,077 $103
Bank of America Corp. — No change 223 $21

"% of holder's portfolio" is GRMLW's weight in each manager's 13F, not the share of Anew Medical Inc. the manager owns.